Each specimen is carefully screened in both the manufacturing process and the quality-control phases. To date, Stemedica has manufactured the equivalent of 30 billion cells, and there has been no report of contamination or rejected lots.
Each specimen is carefully screened in both the manufacturing process and the quality-control phases. To date, Stemedica has manufactured the equivalent of 30 billion cells, and there has been no report of contamination or rejected lots.